معرفی
Rachel Crockett is a Postdoctoral Research Fellow at the University of Oxford’s Institute of Biomedical Engineering, working under Professors Tim Denison and Ben Seymour. Her research focuses on neuromodulation and neurofeedback techniques to treat chronic pain, alongside investigations into neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Previously, she conducted doctoral research at the University of British Columbia (PhD in Rehabilitation Sciences, 2021) and postdoctoral work at Stanford University with Professor Helen Brontë-Stewart, examining neuroimaging methodologies for deep brain stimulation targets in Parkinson’s Disease.
Her expertise spans clinical neuroscience, neuroimaging, and the application of resistance training to mitigate cognitive and mobility impairments in aging populations. Key projects include randomized controlled trials evaluating exercise interventions for vascular cognitive impairment and cerebral small vessel disease. She has contributed to advancing lesion network mapping and tractography techniques to understand functional disruptions in neurological disorders.
Recent work emphasizes interdisciplinary approaches, integrating biomedical engineering with clinical research to develop novel neuromodulation therapies. Rachel’s publications highlight her focus on white matter integrity, cholinergic pathways, and the interplay between physical activity and neurological health. She collaborates with the Denison Group at Oxford, contributing to cutting-edge studies on pain management and aversive learning mechanisms.
